About Startup days
Startup days, an accelerator and incubator program founded in 2004, is based in Bern, Switzerland. With a presence in 4 countries, it has supported around 42 startups in sectors like High Tech, Enterprise Applications. Most notable companies in
its portfolio include AlitheaGenomics, IDUN Technologies and Terapet. The program is backed by a team of 12 people who primarily support startups based in Switzerland, Germany.
Key Metrics
Founded Year
2004
Location
Bern, Switzerland
Portfolio Companies
Sectors of Investment
Locations of Investment
Startup days' List of Top Investments
Startup days has a portfolio of 42 companies. Their most notable investments include AlitheaGenomics and IDUN Technologies.Their portfolio spans across Switzerland, Germany, United Kingdom and 1 more locations. They have invested in High Tech, Enterprise Applications, HealthTech and 18 other sectors. Here is the list of top investments by Startup days:
Provider of transcriptomics solutions for research and biomarker discovery. The company offers proprietary technology for RNA-seq of multiplex RNA samples for sequencing. The company also offers mRNA sequencing services and a kit that can be used for multiple samples.
Key facts about AlitheaGenomics
- Founded Year: 2020
- Location: Lausanne (Switzerland)
- Stage: Seed
- Total Funding till date: $8.13M
- Employee Count: 34 as on May 31, 2026
- Investors: Zurcher Kantonalbank, Venture Kick and 4 Others
- Latest Funding Round: Seed, Mar 04, 2026, $*****
- Highlight: Editors' Pick
Provider of in-ear EEG earbuds to monitor brain activity. The company offers IDUN Guardian an EEG monitoring device that combines hardware and software to monitor and interpret brain waves during sleep and wakefulness.
Key facts about IDUN Technologies
- Founded Year: 2017
- Location: Opfikon (Switzerland)
- Stage: Seed
- Total Funding till date: $3.74M
- Employee Count: 25 as on May 31, 2026
- Investors: Venture Kick, EIC Fund and 9 Others
- Latest Funding Round: Seed, Sep 03, 2021, $*****
- Highlight: Editors' Pick
3. Terapet
Developer of integrated imaging solutions for proton therapy and nuclear medicine. It develops innovative platform technology for imaging in nuclear medicine, advancing proton therapy and nuclear imaging. The company's products enable quality and new clinical nuclear imaging in patient diagnosis and treatment, aiming to become a leading choice for radiotherapy and precision medicine. Its mission is to use its platform technology to create integrated imaging solutions that improve proton therapy, nuclear imaging, and precision medicine.
Key facts about Terapet
- Founded Year: 2019
- Location: Geneva (Switzerland)
- Stage: Seed
- Total Funding till date: $3.75M
- Employee Count: 14 as on May 31, 2026
- Investors: Nina Capital, Venture Kick and 10 Others
- Latest Funding Round: Grant (prize money), Mar 01, 2024, $*****
4. Enlightra
Provider of photonic integrated circuits for applications in data centres. It uses light to enable data transmission. It designs and develops multi-colour laser systems for applications in data communication and optical computing systems.
Key facts about Enlightra
- Founded Year: 2016
- Location: Lausanne (Switzerland)
- Stage: Series A
- Total Funding till date: $15.5M
- Employee Count: 27 as on May 31, 2026
- Investors: Pegasus Tech Ventures, Y Combinator and 12 Others
- Latest Funding Round: Series A, Dec 18, 2025, $*****
5. Scailyte
Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery. The company is developing AI software for single-cell data analysis to discover novel biomarkers for the early and precise detection of a wide range of complex diseases. This AI-based single-cell technology can also be used for the identification of relevant single-cell patterns from mass cytometry data.
Key facts about Scailyte
- Founded Year: 2017
- Location: Basel (Switzerland)
- Stage: Series A
- Total Funding till date: $20.3M
- Employee Count: 18 as on May 31, 2026
- Investors: Zurcher Kantonalbank, Verve Ventures and 7 Others
- Latest Funding Round: Series A, Dec 05, 2023, $*****
- Highlight: Editors' Pick
